HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 06-01-2003, 08:48 PM   #1
Lolly
Guest
 
Posts: n/a
In Phase III trials patients with metastatic breast cancer who received WBR plus RSR13 achieved longer survival. RSR13 works by sensitizing oxygen-deprived tumor tissues to enhance the effectiveness of standard radiation therapy and chemotherapy.
  Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 06:48 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter